SEARCH
Bharat Biotech to conduct Phase 3 trials for COVAXIN
Aaj Tak
2020-10-24
Views
5
Description
Share / Embed
Download This Video
Report
The Bharat Biotech will be conducting Phase 3 trials for its Covid-19 vaccine candidate, COVAXIN, in 25 centres across India and a total of 26,000 people will be participating in the Phase 3 trials. Watch the video for more details.
Show more
Share This Video
facebook
google
twitter
linkedin
email
Video Link
Embed Video
<iframe width="600" height="350" src="https://dailytv.net//embed/x7x13al" frameborder="0" allowfullscreen></iframe>
Preview Player
Download
Report form
Reason
Your Email address
Submit
RELATED VIDEOS
02:48
Corona: Bharat Biotech starts Phase III trials for COVAXIN
00:50
Animal trials of Bharat Biotech Covaxin vaccine successful
04:53
Phase 2 trials for Bharat Biotech vaccine to begin in Sept
04:24
Can Covaxin be given to children? Bharat Biotech CMD answers
17:28
Bharat Biotech inks deal to supply Covaxin to Brazil
03:37
Bharat Biotech vaccine Covaxin to get WHO nod soon?
01:28
Covaxin gets DCGI nod to conduct clinical trials on children
06:16
Phase 2 human trials for COVAXIN to begin in September
01:00
3rd phase trials of Covaxin begins:Here's what Anil Vij said
12:38
Panel recommends phase 2/3 trials of Covaxin on children
04:30
Will Bharat Biotech's Covaxin get green signal from WHO?
11:29
Bharat Biotech's Covaxin can be used as back-up for now